期刊文献+

不同氧浓度对原代培养人早孕绒毛细胞滋养细胞血管内皮生长因子及其可溶性受体表达的影响 被引量:9

Expression of Vascular Endothelial Growth Factor and Soluble Fms-like Tyrosine Kinase Receptor 1 under Different Oxygen Condition in the Primary Cultured Cytotrophoblast Cells of Human
下载PDF
导出
摘要 目的:探讨原代培养人早孕绒毛细胞滋养层细胞(CT)在缺氧时血管内皮生长因子(VEGF)和可溶性血管内皮生长因子受体-1(sFlt-1)的表达。方法:将经胰蛋白酶/DNA酶Ⅰ联合消化通过Percoll分离纯化得到的细胞滋养层细胞进行原代培养。采用ELISA法测定正常氧浓度(20%O2,A组)、低氧浓度Ⅰ组(8%O2,B组)和Ⅱ组(2%O2,C组)及低氧复氧组(2%O2/20%O2,D组)培养的不同时段细胞上清液中VEGF和sFlt-1蛋白的表达。结果:B组、C组于培养72h、96h、120h、144h时间点测得VEGF、sFlt-1的浓度明显高于A组(P<0.01);D组于培养96h、120h、144h后测得VEGF、sFlt-1的浓度较72h低,且分别与A组同期相比无明显差异(P>0.05)。结论:细胞滋养层细胞在低氧条件下VEGF、sFlt-1分泌增加,低氧复氧后VEGF和sFlt-1表达均恢复正常。 Objective: To investigate the expression of vascular endothelial growth factor (VEGF) and soluble fins-like tyrosine kinase receptor 1 (sFlt-1) under different oxygen concentrations in cytotrophoblast cells. Methods: Cytotrophoblast cells of human early-pregnancy were collected by trypsin-collagenase digestion and Percoll gradient centrifugation for primary culture. Cytotrophoblast cells were cultured under group A (normoxic group,20%O2), group B(8%O2), group C (2%O2), group D (hypoxic and reoxygenation group 2%O2/20%O2), respectively.VEGF and sFlt-1 concentrations at different incubation periods in each culture media were measured using ELISA. Results: The VEGF and sFlt-1 concentrations in group B and group C were significantly higher than those in group A when measured at 72 h, 96 h, 120 h, 144 h in culured (P〈0.01). VEGF and sFlt-1 concentrations in group D at 96 h, 120 h,144 h in cultured were lower than that at 72 h. The VEGF and sFlt-1 concentrations at 96 h,120 h ,144 h had no obviously difference compared with group A (P〉0.05). Conclusion: VEGF and sFlt-1 concentrations increase in response to hypoxic, VEGF and sFlt-1 concentratiohs were to recover common after hypoxic and reoxygenation.
出处 《生殖与避孕》 CAS CSCD 北大核心 2008年第4期222-225,251,共5页 Reproduction and Contraception
关键词 细胞滋养层细胞(CT) 血管内皮生长因子(VEGF) 血管内皮生长因子受体-1(sFlt-1) cytotrophoblast vascular endothelial growth factor (VEGF) vascular endothelial growth factor receptor l(sFlt- 1)
  • 相关文献

参考文献8

  • 1Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science, 2005, 308 (5 728): 1 592-4.
  • 2Merviel P, Carvillon L, Challier JC, et al. Pathophysiology of preeclampsia:links with implantation disorders. European J Obstet Gynecol Reprod Biol, 2004, 115(2):134-47.
  • 3Kliman H J, John EN, Eduardo S, et al. Purification, characterization,and in vitro differentiation of cytotrophoblasts from human term placentae. Endocrinology, 1986, 118(4): 1567-82.
  • 4Genbaeev O, Zhou Y, Ludlow JW, et al. Regulation of human placental development by oxygen tension. Science, 1997, 277(5 332):1 669-72.
  • 5Esterman A, Greco MA, Mitani Y, et al. The effect ofhypoxia on human trophoblast in cultrue: morphology, glucose transport and metabolism. Placenta, 1997,18(2-3):129-36.
  • 6Nagamatsu T, Fujii T, Kusumi M, et al. Cytotrophoblasts up-regulate soluble fins-like tyrosine kinase-1 expression under reduced oxygen:an implication for the placental vascular development and the pathophysiology of prceclampsia. Endocrinology, 2004, 145(11):4 838-45.
  • 7Ahmad S, Ahmed A. Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia. Cite Res, 2004, 95(9):884-91.
  • 8傅勤,林建华.血管内皮生长因子在子痫前期发病机制中的研究[J].国外医学(妇产科学分册),2006,33(1):23-26. 被引量:5

二级参考文献19

  • 1Carr DB,McDonald GB,Brateng D,et al.The relationship between hemodynamics and inflammatory activation in women at risk for preeclampsia.Obstet Gynecol (United States),2001,98(6):1109-1116.
  • 2Sibai BM.Preeclampsia:An inflammatory syndrome? Am J Obstet Gynecol,2004,191(4):1061-1062.
  • 3Ferrara N,Gerber HP,LeCouter J.The biology of VEGF and its receptors.Nat Med,2003,9(6):669-676.
  • 4Evans PW,Wheeler T,Anthony FW,et al.A longitudinal study of maternal serum vascular endothelial growth factor in early pregnany.Hum Reprod ,1998,13(4):1057-1062.
  • 5Tsatsaris V,Goffin F,Munaut C,et al.Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients:Pathophysiological Consequences.J Clin Endocrinol Metab,2003,88(11):5555 - 5563.
  • 6McKeeman GC,Ardill JE,Caldwell CM,et al.Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop.Am J Obstet Gynecol,2004,191(4):1240-1246.
  • 7Chaiworapongsa T,Romero R,Kim YM,et al.Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia.J Matern Fetal Neonatal Med,2005,17(1):3-18.
  • 8Koga K,Osuga Y,Yoshino O,et al.Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia.J Clin Endocrinol Metab,2003,88(5):2348-2351.
  • 9Chaiworapongsa T,Romero R,Espinoza J,et al.Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia.Young Investigator Award.Am J Obstet Gynecol,2004,190(6):1541-1547.
  • 10Maynard SE,Min JY,Merchan J,et al.Excess placental soluble fmslike tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction,hypertension,and proteinuria in preeclampsia.J Clin Invest ,2003,111(5):649-658.

共引文献4

同被引文献100

  • 1吴维光,陈亚琼,王玉萍,张明静.不同缺氧方法诱导BeWo细胞缺氧诱导因子 1α表达的实验研究[J].武警医学院学报,2005,14(2):86-89. 被引量:4
  • 2谭兵兵,王乾兴,谭晓珊,刘华庆.胎盘绒毛血管生成状况及VEGF、MMP-2和MMP-9表达与早期自然流产的关系[J].生殖与避孕,2006,26(8):477-482. 被引量:26
  • 3Koga K, Osuga Y, Yoshino O, et al. Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia. J Clin Endocrinol Metab, 2003, 88(5):2348-51.
  • 4Korean J. Increased sFlt-1 to PIGF ratio in women who subsequently develop preeclampsia. Med Sci, 2007, 22 (5):873-7.
  • 5Chaiworapongsa T, Romero R, Espinoza J, et al. Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award. Am J Obstet Gynecol, 2004, 190 (6): 1541-50.
  • 6Polliotti BM, Fry AG, Sailer DN, et al. Secondtrimester maternal serum placental growth factor and vascular endothelial growth factor for predicting severe, early-onset preeclampsia. Obstet Gynecol, 2003, 101(6): 1266-74.
  • 7Tsatsaris V, Goffin F, Munaut C, et al. Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients:pathophysiological consequences. J Clin Endocrinol Metab, 2003, 88(11):5555-63.
  • 8Feng HC, Choy MY, Deng W, et al. Establishment and characterization of a human first-trimester extravillous trophoblast cell line (TEV-1). J Soc Gynecol Investig, 2005, 12(4):21-32.
  • 9Lockwood C J, Toti P, Arcuri F, et al. Thrombin regulates soluble fms-like tyrosine kinase-1 (sFlt-1) expression in first trimester decidua:implications for preeclampsia. Int J Fertil Womens Med, 2007, 52(2-3):59-67.
  • 10Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocrine Rev, 2004, 25(4):581-611.

引证文献9

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部